Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Ovarian cancer
Closed
Phase 3
This trial is looking at a drug called olaparib for ovarian cancer, fallopian tube cancer or primary peritoneal cancer that has a change to a gene called BRCA1 or BCRA2.
Recruitment start: 26 November 2013
Recruitment end: 10 October 2014
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Last reviewed: 24 Nov 2014
CRUK internal database number: 11334
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
